{"issuance_frequency":"","notes_translated":{"fr":"Le 13 décembre 2017, Santé Canada a publié le Règlement modifiant le Règlement sur les aliments et drogues (exigences de DIN pour les drogues sous forme posologique figurant à l'annexe C de la Loi sur les aliments et drogues) dans la Partie II de la Gazette du Canada. L'objectif de cette modification réglementaire est d'exiger que les drogues de l'annexe C (radiopharmaceutiques et trousses) portent une identification numérique de drogue (DIN) pour qu'elles puissent être vendues au Canada. En plus de la nouvelle exigence d'avoir une DIN pour toutes les drogues de l'annexe C, les conditions d'étiquetage ont également été mises à jour pour refléter la nouvelle exigence. Ainsi, au lieu d'exiger que le numéro de licence d'établissement figure sur l'étiquette, dorénavant c'est la DIN qui doit y figurer.","en":"On December 13, 2017, Health Canada published the Regulations Amending the Food and Drug Regulations (DIN Requirements for Drugs in Dosage Form Listed in Schedule C to the Food and Drugs Act) in Canada Gazette, Part II. The objective of this regulatory amendment is to apply to Schedule C Drugs (radiopharmaceuticals and kits), the requirement to have a Drug Identification Number (DIN) in order for a drug to be sold in Canada. Along with the new requirement for all Schedule C drugs to have a DIN, the labelling requirements have also been updated to reflect the new requirement: instead of requiring the Establishment Licence number to be on the label, there will now be a requirement for the DIN to be on the label."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"7d597661-6ef1-4f6d-8f84-4610b5d58339","metadata_created":"2021-07-06T15:41:40.850437","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-06T15:41:40.850445","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-06","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Document d'orientation","DIN","numéros d'identification des médicaments","médicaments de l'annexe C","produits radiopharmaceutiques et trousses","modification réglementaire","Règlement sur les aliments et drogues","médicaments sous forme posologique","l'exigence","un DIN","un médicament devant être vendu au Canada","les exigences en matière d'étiquetage","le nouveau exigence","le DIN doit figurer sur l'étiquette"],"en":["Guidance document","DIN","drug identification numbers","schedule C drugs","radiopharmaceuticals and Kits","regulatory amendment","Food and Drug Regulations","drugs in dosage form","the requirement","a DIN","a drug to be sold in Canada","the labelling requirements","the new requirement","DIN to be on the label"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Ligne directrice : Identification numérique pour les drogues de l'annexe C (radiopharmaceutiques et trousses)","en":"Guidance Document: Drug Identification Numbers for Schedule C Drugs (Radiopharmaceuticals and Kits)"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"7d597661-6ef1-4f6d-8f84-4610b5d58339","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4f35c0ac-9050-433a-8ebc-118db8475063","related_relationship":"","name_translated":{"fr":"Ligne directrice : Identification numérique pour les drogues de l'annexe C (radiopharmaceutiques et trousses)","en":"Guidance Document: Drug Identification Numbers for Schedule C Drugs (Radiopharmaceuticals and Kits)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance Document: Drug Identification Numbers for Schedule C Drugs (Radiopharmaceuticals and Kits)","language":["en"],"created":"2021-07-06T15:41:40.949286","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/drug-identification-numbers-schedulec-2019/document.html#s1","last_modified":null,"position":0,"revision_id":"952ed1e1-724e-4b22-9ff1-82dc0da32954","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"7d597661-6ef1-4f6d-8f84-4610b5d58339","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4eb8b604-1f62-406f-a59b-289aaa918444","related_relationship":"","name_translated":{"fr":"Ligne directrice : Identification numérique pour les drogues de l'annexe C (radiopharmaceutiques et trousses)","en":"Guidance Document: Drug Identification Numbers for Schedule C Drugs (Radiopharmaceuticals and Kits)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance Document: Drug Identification Numbers for Schedule C Drugs (Radiopharmaceuticals and Kits)","language":["fr"],"created":"2021-07-06T15:41:40.949293","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/identification-numerique-drogues-annexec-2019/document.html","last_modified":null,"position":1,"revision_id":"952ed1e1-724e-4b22-9ff1-82dc0da32954","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-05-05 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"7d597661-6ef1-4f6d-8f84-4610b5d58339","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"On December 13, 2017, Health Canada published the Regulations Amending the Food and Drug Regulations (DIN Requirements for Drugs in Dosage Form Listed in Schedule C to the Food and Drugs Act) in Canada Gazette, Part II. The objective of this regulatory amendment is to apply to Schedule C Drugs (radiopharmaceuticals and kits), the requirement to have a Drug Identification Number (DIN) in order for a drug to be sold in Canada. Along with the new requirement for all Schedule C drugs to have a DIN, the labelling requirements have also been updated to reflect the new requirement: instead of requiring the Establishment Licence number to be on the label, there will now be a requirement for the DIN to be on the label.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance Document: Drug Identification Numbers for Schedule C Drugs (Radiopharmaceuticals and Kits)","revision_id":"952ed1e1-724e-4b22-9ff1-82dc0da32954"}